Nyhetsflöde

Regulatoriska pressmeddelanden

Icke regulatoriska pressmeddelanden och nyheter

26 maj 2023

Glad to have these colleagues presenting the amorphOX® drug delivery platform at the Novel Nasal Formulation & Deli… https://t.co/bLVUITar8c

24 maj 2023

Tomorrow we will join Bolagsdagen hosted by Erik Penser Bank. An IRL event with more than 300 participants + 60 pre… https://t.co/l2M5u5w8CO

22 maj 2023

Our partner @gesynta Pharma is developing a novel treatment for #endometriosis (phase II). Today they announces the… https://t.co/Ue74yAbNJ1

Europa

USA

Lena Wange

IR & Corporate Communications Director

Växel: +46 (0)18 780 88 00

Direktnummer: +46 73 064 16 36

Email: ir@orexo.com

Plats: Uppsala, Sverige

Robert A. DeLuca

President Orexo US Inc.

Växel: +1 (0)855 982 7658

Email: us.media@orexo.com

Plats: New Jersey, US